Alert
Close

   

Enter the Family Fun Travel Sweepstakes. No purchase necessary. See official rules

HIGHLIGHTS

Open
AARP Staying Sharp: Keep Your Brain Healthy

AARP VETERAN MEMBERSHIP

Military and Veterans Discount

AARP REALPAD

The tablet with free 24/7 customer support. Learn More

CONTESTS AND SWEEPS

You Could Choose Your Dream Vacation

KEEP BRAIN ACTIVE!

AARP Games - Play Now!

Learning Centers

Get smart strategies for managing health conditions.


Arthritis

Heart Disease

Diabetes

Most Popular

Viewed

Health Discovery

Vitamin A May Be Key to Better Breast Cancer Drugs

Generic Drugs in Bottles

— Getty Images/Comstock Images

STUDY FINDINGS:

A form of retinoic acid, a vitamin A derivative, could lead to a new drug combination for breast cancer treatment.


A recent study from the University of Chicago may lead to new treatments for common breast cancers that don’t respond to traditional therapies. Using cells taken from patients with estrogen-related breast cancers, researchers at the Institute for Genomics and System Biology compared how the receptors of estrogen and retinoic acid, a derivative of vitamin A, affected the genes involved in breast cancer. (Receptors, often described as the ears or antennae on a cell, can send signals for breast cancer cells to grow.)

The results, reported in the June 26 issue of the journal Cell, found that the estrogen receptor and the retinoic acid receptor appeared to compete with each other to activate or repress many of the same genes, according to Kevin White, director of the institute and one of the study’s authors. “What we found was not only that these receptors target many of the same breast cancer genes, but also that they have an antagonistic relationship,” he says. Estrogen can send signals that tell breast cancer cells to grow, while retinoic acid seems to inhibit cellular growth. “We call it a yin yang effect,” White says.

Retinoic acid has been approved for the treatment of promyelocytic leukemia, but it can be quite toxic. The goal is to develop a retinoic acid derivative with similar structure and function but with a much lower toxicity that could be used in combination with standard drugs like tamoxifen, or to develop new anticancer drugs. “These studies suggest that combining drugs that target the retinoic acid pathway with those targeting the estrogen receptor pathway might prove more fruitful in treatment of breast cancer,” says Harold Burstein, M.D., a breast cancer specialist at the Dana-Farber Cancer Institute in Boston.


Cathie Gandel is a freelance writer who covers health and science.

Topic Alerts

You can get weekly email alerts on the topics below. Just click “Follow.”

Manage Alerts

Processing

Please wait...

progress bar, please wait

Tell Us WhatYou Think

Please leave your comment below.

Advertisement

Discounts & Benefits

From companies that meet the high standards of service and quality set by AARP.

Walgreens 1 discount membership aarp

Members can earn 50 points per $1 spent on select products at Walgreens.

member benefit aarp hear usa

Members can save 20% on hearing aids with the AARP® Hearing Care Program provided by HearUSA.

AARP membership discount Man trying on eyeglasses at optometrists smiling

Members save up to 60% on eye exams and 30% on glasses at LensCrafters.

Membership Benefits Discounts Email Genius

Brain boost? Get AARP email for access to memory exercises & more that help you focus.

Advertisement